191 related articles for article (PubMed ID: 6530392)
21. Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
Atha DH; Stephens AW; Rimon A; Rosenberg RD
Biochemistry; 1984 Nov; 23(24):5801-12. PubMed ID: 6525337
[TBL] [Abstract][Full Text] [Related]
22. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
Mourier PA; Guichard OY; Herman F; Viskov C
Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
[TBL] [Abstract][Full Text] [Related]
23. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
[TBL] [Abstract][Full Text] [Related]
24. Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implications.
Daud AN; Ahsan A; Iqbal O; Walenga JM; Silver PJ; Ahmad S; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):58-64. PubMed ID: 11190907
[TBL] [Abstract][Full Text] [Related]
25. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
Nesheim M; Blackburn MN; Lawler CM; Mann KG
J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
[TBL] [Abstract][Full Text] [Related]
26. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
Marciniak E; Gora-Maslak G
Thromb Res; 1982 Nov; 28(3):411-21. PubMed ID: 7179225
[TBL] [Abstract][Full Text] [Related]
27. Effects of different heparins on the enhancement of the thrombin-antithrombin reaction.
Oshima G
Biol Chem Hoppe Seyler; 1990 Jan; 371(1):37-42. PubMed ID: 2322419
[TBL] [Abstract][Full Text] [Related]
28. Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition.
Duchaussoy P; Jaurand G; Driguez PA; Lederman I; Ceccato ML; Gourvenec F; Strassel JM; Sizun P; Petitou M; Herbert JM
Carbohydr Res; 1999 Apr; 317(1-4):85-99. PubMed ID: 10466208
[TBL] [Abstract][Full Text] [Related]
29. New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin.
Mourier PA; Guichard OY; Herman F; Sizun P; Viskov C
Molecules; 2017 Mar; 22(3):. PubMed ID: 28282887
[TBL] [Abstract][Full Text] [Related]
30. The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin.
Heuck CC; Schiele U; Horn D; Fronda D; Ritz E
J Biol Chem; 1985 Apr; 260(8):4598-603. PubMed ID: 3988727
[TBL] [Abstract][Full Text] [Related]
31. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
Turk B; Brieditis I; Bock SC; Olson ST; Björk I
Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
[TBL] [Abstract][Full Text] [Related]
32. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
33. Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.
Xiao Z; Zhao W; Yang B; Zhang Z; Guan H; Linhardt RJ
Glycobiology; 2011 Jan; 21(1):13-22. PubMed ID: 20729345
[TBL] [Abstract][Full Text] [Related]
34. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
Volpi N; Maccari F
Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of heparins from different commercial sources.
Zhang F; Yang B; Ly M; Solakyildirim K; Xiao Z; Wang Z; Beaudet JM; Torelli AY; Dordick JS; Linhardt RJ
Anal Bioanal Chem; 2011 Nov; 401(9):2793-803. PubMed ID: 21931955
[TBL] [Abstract][Full Text] [Related]
37. Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases.
Rice KG; Linhardt RJ
Carbohydr Res; 1989 Jul; 190(2):219-33. PubMed ID: 2805009
[TBL] [Abstract][Full Text] [Related]
38. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
[TBL] [Abstract][Full Text] [Related]
39. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.
Casu B; Oreste P; Torri G; Zoppetti G; Choay J; Lormeau JC; Petitou M; Sinäy P
Biochem J; 1981 Sep; 197(3):599-609. PubMed ID: 7325974
[TBL] [Abstract][Full Text] [Related]
40. Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II.
Tollefsen DM; Sugimori T; Maimone MM
Semin Thromb Hemost; 1990 Oct; 16 Suppl():66-70. PubMed ID: 1962908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
